The role of ephrins' receptors and ephrins' ligands in normal placental development and disease

Expert Opinion on Therapeutic Targets

Volumn 18, Issue 3, 2014, Pages 269-275

  Chatzizacharias, Nikolaos A ^a,b   Giaginis, Constantinos T ^a,c   Agapitos, Emmanuel ^a   Theocharis, Stamatios E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF THE AEGEAN   (Greece)

Author keywords

Embryonic development; Ephrins; Placenta; Placental pathology

Indexed keywords

ANIMALS; EPHRINS; FEMALE; HUMANS; LIGANDS; PLACENTA ACCRETA; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, EPH FAMILY;

EID: 84894195354     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2014.864638     Document Type: Review

References (42)

1. Zhang J, Hughes SE. Role of the ephrin and Ephrin receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J Pathol 2006;208: 453-61
2. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008;133: 38-52 • An outstanding article on the crucial role of Eph-ephrin signalling in physiology and disease.
3. Nakamoto M, Bergemann AD. Diverse role for the Eph family of receptor tyrosine kinases in carcinogenesis. Microscopy Res Technique 2002;59: 58-67
4. Surawska H, Ma PC, Salgia R. The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 2004;15: 419-33
5. Cheng N, Brantley DM, Chen J. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 2002;13: 75-85
6. Himanen J-P, Nikolov DB. Eph receptors and ephrins. Int J Biochem Cell Biol 2003;35: 130-4
7. Holder N, Klein R. Eph receptors and ephrins: effectors of morphogenesis. Development 1999;126: 2033-44
8. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 2005;6: 462-75
9. Adams RH. Molecular control of arterialevenous blood vessel identity. J Anat 2003;202: 105-12
10. Mellitzer G, Xu Q, Wilkinson DG. Eph receptors and ephrins restrict cell intermingling and communication. Nature 1999;1: 77-81
11. Klein R. Excitatory Eph receptors and adhesive ephrin ligands. Curr Opin Cell Biol 2001;13: 196-203
12. Davy A, Robbins SM. Ephrin-A5 modulates cell adhesion and morphology in an integrin-dependent manner. EMBO J 2001;16: 5396-405
13. Mi S, Lee X, Li X, et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000;403: 785-9
14. Huppertz B, Frank HG, Kingdom JC, et al. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1998;110: 495-508
15. Potgens AJ, Schmitz U, Bose P, et al. Mechanisms of syncytial fusion: a review. Placenta 2002;23(Suppl A):S107-13
16. Bischof P, Irminger-Finger I. The human cytotrophoblastic cell, a mononuclear chameleon. Int J Biochem Cell Biol 2005;37: 1-16
17. Benirschke K, Kaufmann P. Pathology of the human placenta. 3rd edition. Springer-Verlag; New York, USA: 1995
18. Sapin V, Bouillet P, Oulad-Abdelghani M, et al. Differential expression of retinoic acid-inducible (Stra) genes during mouse placentation. Mech Dev 2000;92: 295-9
19. Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor EphB4. Cell 1998;93: 741-53
20. Zhang J, Dong H, Wang B, et al. Dynamic changes in patterns of endometrial EFNB2/EPHB4 expression during the period of spiral arterial modification in mice. Biol Reprod 2008;79: 450-8
21. Goldman-Wohl D, Greenfield C, Haimov-Kochman R, et al. Eph and ephrin expression in normal placental development and preeclampsia. Placenta 2004;25: 623-30 • An article of considerable importance which provided substantial evidence for the cellular distribution and expression patterns of representative Ephs and ephrins in trophoblast migration during normal placental development and placental pathologies.
22. Chennakesava CS, Di Santo S, Ziemiecki A, et al. Differential expression of the receptor tyrosine kinase EphB4 and its ligand Ephrin-B2 during human placental development. Placenta 2006;27: 959-67 • A thorough paper which provided substantial evidence that EphB4 and ephrin-B2 are instrumental in the development of human placenta.
23. Cross JC, Hemberger M, Lu Y, et al. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol Cell Endocrinol 2002;187: 207-12
24. Red-Horse K, Kapidzic M, Zhou Y, et al. EPHB4 regulates chemokineevoked trophoblast responses: a mechanism for incorporating the human placenta into the maternal circulation. Development 2005;132: 4097-106
25. Adams RH. Molecular control of arterialevenous blood vessel identity. J Anat 2003;202: 105-12
26. Makikallio K, Jouppila P, Rasanen J. Human fetal cardiac function during the first trimester of pregnancy. Heart 2005;334-8
27. Korff T, Braun J, Pfaff D, et al. Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment. Blood 2008;112: 73-81
28. El-Hashash AH, Kimber SJ. PTHrP induces changes in cell cytoskeleton and E-cadherin and regulates Eph/Ephrin kinases and RhoGTPases in murine secondary trophoblast cells. Dev Biol 2006;290: 13-31
29. Fujii H, Tatsumi K, Kosaka K, et al. Eph-ephrin A system regulates murine blastocyst attachment and spreading. Dev Dyn 2006;235: 3250-8
30. Fujii H, Fujiwara H, Horie A, et al. Ephrin A1 induces intercellular dissociation in Ishikawa cells: possible implication of the Eph-ephrin A system in human embryo implantation. Hum Reprod 2011;26: 299-306
31. Ilan N, Madri JA. New paradigms of signaling in the vasculature: ephrins and metalloproteases. Curr Opin Biotechnol 1999;10: 536-40 • A thorough paper which provided substantial evidence that EphB4 and ephrin-B2 are instrumental in the development of human placenta.
32. Hattori M, Osterfield M, Flanagan JG. Regulated cleavage of a contact-mediated axon repellent. Science 2000;289: 1360-5
33. Zhang Y, Fei M, Xue G, et al. Elevated levels of hypoxia-inducible microRNA- 210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med 2012;16: 249-59
34. Wang W, Feng L, Zhang H, et al. Preeclampsia up-regulates angiogenesisassociated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab 2012;97:E1051-9
35. Fujiwara H, Nishioka Y, Matsumoto H, et al. Eph-ephrin A system regulates human choriocarcinoma-derived JEG- 3 cell invasion. Int J Gynecol Cancer 2013;23: 576-82
36. Nobertini R, Lamberto I, Pasquale EB. Targeting Eph receptors with peptides and small molecules: progress and challenges. Semin Cell Dev Biol 2012;23: 51-7
37. Vasileiou I, Adamakis I, Patsouris E, Theocharis S. Ephrins and pain. Expert Opin Ther Targets 2013;17(8): 879-87
38. O'Neal WT, Griffin WF, Dries-Devlin JL, et al. Ephrin-Eph signaling as a potential therapeutic target for the treatment of myocardial infarction. Med Hypotheses 2013;80: 738-44
39. Funk SD, Orr AW. Ephs and ephrins resurface in inflammation, immunity, and atherosclerosis. Pharmacol Res 2013;67: 42-52
40. Coulthard MG, Morgan M, Woodruff TM, et al. Eph/Ephrin signaling in injury and inflammation. Am J Pathol 2012;181: 1493-503
41. Kandouz M. The Eph/Ephrin family in cancer metastasis: communication at the service of invasion. Cancer Metastasis Rev 2012;31: 353-73
42. Nievergall E, Saunders T, Lackmann M. Targeting of EPH receptor tyrosine kinases for anticancer therapy. Crit Rev Oncol 2012;17: 211-32